BioSpace News Archive

Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s health and the treatment of female stress urinary incontinence (SUI), today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11511110 covering Viveve’s treatment to address SUI in women.

Biovica International Biovica, active in cancer diagnostics, announces that the company has employed a sales team of total of eight people to secure a fast and smooth launch and the further commercial development of DiviTum® TKa on the US market.

RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a panel presentation and host 1x1 investor meetings at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference in Miami, FL.

Shanghai MicroPort MedBot (Group) Co., Ltd. (“MicroPort MedBot”) announced that on November 22nd, 2022 MicroPort NaviBot International, LLC in recent collaboration with MicroPort Orthopedics has completed the first clinical use of the SkyWalker™ Robotic System in the United States.

Organ Recovery Systems (ORS) is celebrating the first liver transplants using the LifePort Liver Transporter (LLT) with Vasosol® at Rutgers Medical School in New Jersey and Northwestern Memorial Hospital in Chicago, Illinois.

Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announces the launch of the ExactaMix Pro Automated Compounder, which is expected to be available to customers in the United States in early 2023.

OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet need in the multi-billion-dollar dry eye disease market, announces that the board of directors of the Company, has appointed PKF Littlejohn LLP as its new independent auditor with immediate effect.

COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study being presented at the annual meeting of the Radiological Society of North America.

Kineta, Inc. announced that the Company will present at the Antibody Engineering and Therapeutics Conference, the Antibody Society’s Annual Meeting, to be held in-person in San Diego, CA from December 4-8, 2022.

Kintor Pharmaceutical Limited announced results of phase II clinical trial of pyrilutamide, a potential first-in-class topical drug developed by the company, in China for the treatment of adult female androgeneticalopecia.